<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>The Drug Discovery Protocol</title>
    <!-- Load the Inter font from Google Fonts -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;600;700&display=swap" rel="stylesheet">
    <!-- Load Tailwind CSS -->
    <script src="https://cdn.tailwindcss.com"></script>
    <style>
        body {
            font-family: 'Inter', sans-serif;
        }
    </style>
</head>
<body class="bg-gray-100 text-gray-800 p-4 sm:p-8">

    <!-- Main content container with a rounded, floating effect -->
    <div class="container mx-auto max-w-6xl bg-white rounded-2xl shadow-xl p-6 sm:p-10">
        
        <!-- Main Title -->
        <h1 class="text-4xl sm:text-5xl font-extrabold text-center text-blue-800 mb-4 sm:mb-6">
            The Drug Discovery Protocol
        </h1>
        <p class="text-lg text-center text-gray-600 mb-8 sm:mb-12">
            A step-by-step guide to the complex process of turning a scientific idea into a life-saving medicine.
        </p>

        <!-- Protocol Stages Container -->
        <div class="grid grid-cols-1 md:grid-cols-2 lg:grid-cols-3 gap-6 sm:gap-8">

            <!-- Stage 1: Target Identification & Validation -->
            <div class="bg-blue-50 p-6 rounded-xl shadow-md transition-transform transform hover:scale-105">
           <a href="./Target-Identification-Validation.html"><h2 class="text-2xl font-bold text-blue-700 mb-2">1. Target Identification & Validation</h2> </a>
                <p class="text-gray-700">
                    The journey begins with identifying a specific biological target—a protein, enzyme, or gene—that is crucial to a disease. This target must be validated to ensure that modulating its activity will have the desired therapeutic effect.
                </p>
            </div>

            <!-- Stage 2: Compound Screening & Lead Identification -->
            <div class="bg-purple-50 p-6 rounded-xl shadow-md transition-transform transform hover:scale-105">
                   <a href="./Compound-Screening-Lead-Identification.html"><h2 class="text-2xl font-bold text-blue-700 mb-2">2. Compound Screening & Lead Identification</h2> </a>
                <p class="text-gray-700">
                    Researchers screen vast libraries of small molecules to find "hits" that can interact with the validated target. These initial hits are then refined into "lead" compounds, which show promising activity and selectivity.
                </p>
            </div>

            <!-- Stage 3: Lead Optimization -->
            <div class="bg-emerald-50 p-6 rounded-xl shadow-md transition-transform transform hover:scale-105">

                      <a href="./Lead-optimization.html"><h2 class="text-2xl font-bold text-blue-700 mb-2">3. Lead Optimization</h2> </a>
    
                <p class="text-gray-700">
                    The lead compounds are chemically modified to improve their potency, selectivity, and stability. This stage aims to create a safe and effective drug candidate with the best possible properties for human use.
                </p>
            </div>

            <!-- Stage 4: Preclinical Development -->
            <div class="bg-amber-50 p-6 rounded-xl shadow-md transition-transform transform hover:scale-105">
                 <a href="./Preclinical-Development.html"><h2 class="text-2xl font-bold text-blue-700 mb-2">4. Preclinical Development</h2> </a>
              
                <p class="text-gray-700">
                    The drug candidate is tested extensively in laboratory and animal studies. This phase is critical for gathering data on the drug's safety, toxicity, pharmacokinetics (how the body affects the drug), and pharmacodynamics (how the drug affects the body).
                </p>
            </div>

            <!-- Stage 5: Clinical Trials -->
            <div class="bg-red-50 p-6 rounded-xl shadow-md transition-transform transform hover:scale-105">
                <a href="./Clinical-Trials.html"><h2 class="text-2xl font-bold text-blue-700 mb-2">5. Clinical Trial</h2> </a>
    
                <p class="text-gray-700">
                    If preclinical results are promising, the drug moves to human testing in three phases:
                    <ul class="list-disc list-inside mt-2 text-sm text-gray-600 space-y-1">
                        <li><strong>Phase 1:</strong> Safety and dosage in a small group of healthy volunteers.</li>
                        <li><strong>Phase 2:</strong> Efficacy and side effects in a larger group of patients.</li>
                        <li><strong>Phase 3:</strong> Confirmation of efficacy and monitoring of adverse reactions in a large patient population.</li>
                    </ul>
                </p>
            </div>

            <!-- Stage 6: Regulatory Approval & Post-Market Surveillance -->
            <div class="bg-sky-50 p-6 rounded-xl shadow-md transition-transform transform hover:scale-105">
                        <a href="./Regulatory-Approval-Post-Market-Surveillance.html"><h2 class="text-2xl font-bold text-blue-700 mb-2">6. Regulatory Approval & Post-Market Surveillance</h2> </a>
                <p class="text-gray-700">
                    Finally, a comprehensive application is submitted to a regulatory body (like the FDA). Once approved, the drug becomes available to the public. Post-market surveillance continues to monitor long-term safety and effectiveness.
                </p>
            </div>

        </div>

    </div>

</body>
</html>
